Dolby Laboratories (DLB) Tops Q1 EPS by 18c, provides guidance

Dolby Laboratories (NYSE: DLB) reported Q1 EPS of $1.06, $0.18 better than the analyst estimate of $0.88. Revenue for the quarter came in at $347 million versus the consensus estimate of $332.07 million.

GUIDANCE:

Dolby Laboratories sees Q2 2026 EPS of $1.29-$1.44, versus the consensus of $1.37. Dolby Laboratories sees Q2 2026 revenue of $375-405 million, versus the consensus of $383.8 million.

Dolby Laboratories sees FY2026 EPS of $4.30-$4.45, versus the consensus of $4.27. Dolby Laboratories sees FY2026 revenue of $1.4-1.45 billion, versus the consensus of $1.415 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Accenture shares fall on insider sales and analyst downgrade
• Zefiro Methane closes C$5M non-brokered private placement